Chih‐Jian Lih
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 2
-
- Genetic factors in colorectal cancer 3
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 2
- Hematology top 10%
-
- Cancer Genomics and Diagnostics 7
-
- Genomics and Phylogenetic Studies 3
- Gene expression and cancer classification 3
- Molecular Biology Techniques and Applications 2
-
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Stanley N. CohenKuang‐Hung PanJianqiang HuangAlessandra TedeschiFong ClowCarol MorenoFatih DemırkanMartin Šimkovič
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Journal of Clinical Oncology (3 papers)Genes & Development (2 papers)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Chih‐Jian Lih
21 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Genetics 399
- Pathology and Forensic Medicine 392
- Pharmacology 267
- Hematology 107
- Immunology 194
Countries citing papers authored by Chih‐Jian Lih
This map shows the geographic impact of Chih‐Jian Lih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Jian Lih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Jian Lih more than expected).
Fields of papers citing papers by Chih‐Jian Lih
This network shows the impact of papers produced by Chih‐Jian Lih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Jian Lih. The network helps show where Chih‐Jian Lih may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chih‐Jian Lih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trialbreakdown → | 2018 | 380 |
| 2 | 2018 | 22 | |
| 3 | 2017 | 15 | |
| 4 | 2016 | 12 | |
| 5 | 2016 | 9 | |
| 6 | 2016 | 4 | |
| 7 | 2015 | 3 | |
| 8 | 2015 | 79 | |
| 9 | 2015 | 0 | |
| 10 | 2014 | 6 | |
| 11 | 2012 | 6 | |
| 12 | 2008 | 21 | |
| 13 | 2006 | 52 | |
| 14 | 2005 | 158 | |
| 15 | 2005 | 114 | |
| 16 | 2005 | 77 | |
| 17 | 2001 | 166 | |
| 18 | TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence. | 2000 | 57 |
| 19 | 1996 | 51 | |
| 20 | 1995 | 3 |
About Chih‐Jian Lih
Chih‐Jian Lih is a scholar working on Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Genetic factors in colorectal cancer (3 papers), Genomics and Phylogenetic Studies (3 papers), Gene expression and cancer classification (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Molecular Biology Techniques and Applications (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Genetics (399 citations), Pathology and Forensic Medicine (392 citations) and Pharmacology (267 citations). Chih‐Jian Lih has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include Stanley N. Cohen, Kuang‐Hung Pan, Jianqiang Huang, Alessandra Tedeschi, Fong Clow, Carol Moreno, Fatih Demırkan, Martin Šimkovič, Jan Novák and Danelle F. James. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.